le mercredi 17 octobre 2018, à 06:27. Posté
par Shannon
I'll put her on http://the72.co.uk/healthy-gc-pro-3464.pdf healthy gc pro Immunocore's technology relies on a new type of medicines it calls "ImmTACs." These drugs exploit the power of T cell receptors -- a part of the immune system -- to recognize changes that occur inside cells during cancer or viral infection. ImmTACs then activate the immune system to kill targeted cells.